sglt2 vs glp 1 Renal outcomes of inhibitors and GLP1 agonists in clinical practice Cardiovascular benefits of SGLT2 inhibitors
Description
Common side effects include gastrointestinal issues, with serious risks like pancreatitis
The information in this article is produced for a U.S
doi: 10.1172/JCI7449
Better glycaemic control and healthier body weight with clinical trials showing up to 22.5% weight loss in some individuals
30031-7/asset/bedae7b4-4f80-4686-b4c7-9c3f908ac1bd/main.assets/gr1.jpg)
